NYSE · INDUSTRIAL ORGANIC CHEMICALS · LARGE CAP
Lyondellbasell Industries N.v. LYB
15 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY12 YEARS OF DIVIDEND GROWTH
Revenue · FY2025
$30.2B
▼ 9.7% vs FY2024
Dividend streak
12 yrs
Raised every year since 2014
EPS · FY25
$-2.34
Dividend / sh · FY25
$5.45
Payout · FY25
-239%
ROE · FY25
-6.5%
Net margin · FY25
-2.4%
Dividend coverage
-0.4×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 30.2B
Revenue, FY2025 · full 15-year series below
Revenue
Net income
The company lost 2 cents on every revenue dollar this year.
Per share
USD -2.34
Diluted EPS, FY2025
EPS
Dividend
The dividend was paid in a year without profit.
Profitability
-6.5%
Return on equity, FY2025
ROE
Operating margin-1.4%
Net margin-2.4%
Return on assets-2.1%
Each USD of equity lost 7 cents this year.
Returned to shareholders
USD 2.0B
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 1.8B
Net buybacksUSD 201.0M
Share of profit-266.3%
Consecutive raises12 years
USD 1.8B in dividends and USD 201.0M in buybacks went back to shareholders in a year without profit.
Growth
+2.2% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−15.8%
+2.2%
−0.8%
Dividend / share
+5.1%
+5.3%
+6.0%
Returned to shareholders
−18.8%
+6.9%
−10.7%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.32B
Shares outstanding, FY2025
Change, 5 years−3.6%
Change, 10 years−26.8%
The share count shrank 4% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 34.0B
total assets, end of FY2025
Total assetsUSD 34.0B
EquityUSD 10.1B
CashUSD 3.4B
Gross debtUSD 12.3B
Net debtUSD 8.9B
Current ratio1.77×
Net debt stands at 88% of equity.
History
15 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Revenue $B
30.2
33.4
33.3
50.5
46.2
27.0
33.9
38.1
33.7
28.5
32.7
45.6
44.1
45.4
48.2
Operating income $B
−0.4
1.9
2.7
5.1
6.8
1.6
4.1
5.2
5.5
5.1
6.1
5.7
5.1
4.7
4.3
EBITDA $B
1.0
3.4
4.3
6.4
8.2
2.9
5.4
6.5
6.6
6.1
7.2
6.8
6.1
5.7
5.3
Income tax $B
0.1
0.3
0.4
0.9
1.2
−0.0
0.6
0.6
0.6
1.4
1.7
1.5
1.1
1.3
1.1
Net income $B
−0.7
1.4
2.1
3.9
5.6
1.4
3.4
4.7
4.9
3.8
4.5
4.2
3.9
2.8
2.1
EPS, diluted $
−2.34
4.15
6.46
11.81
16.75
4.24
9.58
12.01
12.23
9.13
9.59
7.99
6.75
4.92
3.74
Dividend / sh $
5.45
5.27
4.94
4.70
4.44
4.20
4.15
4.00
3.55
3.33
3.04
2.70
2.00
4.20
5.05
Payout %
−239
126
76
83
26
98
43
33
29
36
32
34
29
85
135
ROE %
−6.5
10.8
16.6
31.8
56.7
17.8
37.1
48.8
65.1
60.9
60.2
40.2
32.7
26.2
20.3
Shares out B
0.32
0.32
0.32
0.33
0.33
0.33
0.33
0.38
0.39
0.40
0.44
0.49
0.55
0.58
0.57
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
31 of 31
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed